BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 19817780)

  • 1. What about insulin as an immediate first step for type 2 diabetes?
    Rolla AR
    Diabetes Obes Metab; 2009 Nov; 11 Suppl 5():19-22. PubMed ID: 19817780
    [No Abstract]   [Full Text] [Related]  

  • 2. Starting insulin therapy in type 2 diabetes: lesson 2.
    McCall AL
    Curr Diab Rep; 2005 Oct; 5(5):326-8. PubMed ID: 16188165
    [No Abstract]   [Full Text] [Related]  

  • 3. How do detemir and glargine compare when added to oral agents in insulin-naïve patients with type 2 diabetes mellitus?
    Koenen C
    Nat Clin Pract Endocrinol Metab; 2008 Oct; 4(10):E1. PubMed ID: 18806804
    [No Abstract]   [Full Text] [Related]  

  • 4. [Thanks to fast acting insulin analogs, diabetes therapy without hourly schedule].
    MMW Fortschr Med; 2002 Nov; 144(46):71. PubMed ID: 12534091
    [No Abstract]   [Full Text] [Related]  

  • 5. [Report of experiences. Convenient limitation of blood glucose spikes].
    Henniges W
    MMW Fortschr Med; 2001 Feb; 143(5):57. PubMed ID: 11234526
    [No Abstract]   [Full Text] [Related]  

  • 6. Reduced postprandial glycaemic excursion with biphasic insulin Aspart 30 injected immediately before a meal.
    Kapitza C; Rave K; Ostrowski K; Heise T; Heinemann L
    Diabet Med; 2004 May; 21(5):500-1. PubMed ID: 15089801
    [No Abstract]   [Full Text] [Related]  

  • 7. Glucose control in patients with type 2 diabetes based on frequency of insulin glargine administration.
    Housel AK; Shaw RF; Waterbury NV
    Diabetes Res Clin Pract; 2010 May; 88(2):e17-9. PubMed ID: 20144488
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Individualized therapy. Insulin therapy requirements in pregnancy and old age].
    MMW Fortschr Med; 2005 Nov; 147(46):61. PubMed ID: 16358639
    [No Abstract]   [Full Text] [Related]  

  • 9. Pharmacokinetics and pharmacodynamics of the long-acting insulin analog glargine after 1 week of use compared with its first administration in subjects with type 1 diabetes.
    Porcellati F; Rossetti P; Ricci NB; Pampanelli S; Torlone E; Campos SH; Andreoli AM; Bolli GB; Fanelli CG
    Diabetes Care; 2007 May; 30(5):1261-3. PubMed ID: 17303785
    [No Abstract]   [Full Text] [Related]  

  • 10. The importance of titrating starting insulin regimens in patients with type 2 diabetes.
    Garber AJ
    Diabetes Obes Metab; 2009 Nov; 11 Suppl 5():10-3. PubMed ID: 19817778
    [No Abstract]   [Full Text] [Related]  

  • 11. Insulin glargine in combination with nateglinide in people with Type 2 diabetes: a randomized placebo-controlled trial.
    Dashora UK; Sibal L; Ashwell SG; Home PD
    Diabet Med; 2007 Apr; 24(4):344-9. PubMed ID: 17298589
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Combined insulin-sulfonylurea in type II diabetes mellitus--an update].
    Ravina A; Minuchin O
    Harefuah; 1987 Nov; 113(10):285-7. PubMed ID: 3326798
    [No Abstract]   [Full Text] [Related]  

  • 13. Insulin intensification strategies in type 2 diabetes: when one injection is no longer sufficient.
    Garber AJ
    Diabetes Obes Metab; 2009 Nov; 11 Suppl 5():14-8. PubMed ID: 19817779
    [No Abstract]   [Full Text] [Related]  

  • 14. Glycemic control in the hospital: what to do when experts disagree.
    Ham P
    Am Fam Physician; 2010 May; 81(9):1078. PubMed ID: 20433121
    [No Abstract]   [Full Text] [Related]  

  • 15. Premixed biphasic insulin analogs - a choice for pediatric patients with type 2 diabetes rather than type 1 diabetes?
    Danne T
    Pediatr Diabetes; 2006 Feb; 7(1):1-3. PubMed ID: 16489967
    [No Abstract]   [Full Text] [Related]  

  • 16. Diabetes mellitus management in general practice: where are we?
    Staff M
    Aust Fam Physician; 1999 Aug; 28(8):775. PubMed ID: 10495524
    [No Abstract]   [Full Text] [Related]  

  • 17. [Inadequate blood glucose control with oral antidiabetic drugs. Early conversion to insulin].
    MMW Fortschr Med; 2002 Jul; 144(27-28):61. PubMed ID: 12198890
    [No Abstract]   [Full Text] [Related]  

  • 18. Participants' experiences of intensifying insulin therapy during the Treating to Target in Type 2 Diabetes (4-T) trial: qualitative interview study.
    Jenkins N; Hallowell N; Farmer AJ; Holman RR; Lawton J
    Diabet Med; 2011 May; 28(5):543-8. PubMed ID: 21480965
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparative study of insulin lispro and human regular insulin in patients with type 2 diabetes mellitus and secondary failure of oral hypoglycemic agents.
    Ross SA; Zinman B; Campos RV; Strack T;
    Clin Invest Med; 2001 Dec; 24(6):292-8. PubMed ID: 11767232
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An exploratory study of the effect of using high-mix biphasic insulin aspart in people with type 2 diabetes.
    Dashora U; Ashwell SG; Home PD
    Diabetes Obes Metab; 2009 Jul; 11(7):680-7. PubMed ID: 19527481
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.